Progyny, Inc.
PGNY · NASDAQ
Bulios Fair Price
$23.53
13.3% downside
Current Price
$27.13
According to Bulios Fair Price, PGNY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Progyny, Inc. (Progyny) is an American company specializing in providing specialized services in the field of reproductive health. The company offers a range of programs and services for couples and individuals seeking assistance with reproductive issues, including infertility treatment. Progyny focuses on supporting and coordinating treatment, which may include assisted reproduction, in vitro fertilization (IVF), and other methods. Their goal is to help people achieve healthy pregnancies and families. Progyny, Inc. shares may be suitable for investors seeking opportunities in the healthcare and reproductive health sector.
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Pete Anevski
Employees
846
Headquarters
New York City
Upcoming events
Earnings
Upcoming earnings report